Dina R. Eremeeva
Research Subjects
Dina R. Eremeeva has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Marina Sabirovna Zainulina
Snegirev Maternity Hospital No 6; 5 Mayakovskogo Str., Saint Petersburg 192014, Russia; Pavlov First Saint Petersburg State Medical University, Health Ministry of Russian Federation; 6/8 Lev Tol-stoy Str., Saint Petersburg 197022, Russia, Russia
2 shared publications Aleksey E. Blinov
Saint Petersburg Pavlov State Medical University
1 shared publication- Andrey Sergeyevich Glotov
Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynaecology, and Reproductology, 199034 St. Petersburg, Russia
1 shared publication Bezhenar V.F. Bezhenar
1 shared publication- Butenko M.G. Butenko
Department of Genomic Medicine, D.O. Ott Research Institute for Obstetrics, Gynecology and Reproduction, 199034 St. Petersburg, Russia
1 shared publication - Dmitry Mikhailovich Shirokov
Military Medical Academy named after S.M. Kirov; The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott; Academician I.P. Pavlov First St. Petersburg State Medical University
1 shared publication
Latest Publications
- Open Access
High-Throughput Sequencing of Circulating MicroRNAs in Plasma and Serum during Pregnancy Progression
Although circulating microRNAs (miRNAs) in maternal blood may play an important role in regulation of pregnancy progression and serve as non-invasive biomarkers for different gestation complications, little is known about their profile in blood during normally developing pregnancy. In this study we evaluated the miRNA profiles in paired plasma and serum samples from pregnant women without health or gestational abnormalities at three time points using high-throughput sequencing technology. Sequencing revealed that the percentage of miRNA reads in plasma and serum decreased by a third compared to first and second trimesters. We found two miRNAs in plasma (hsa-miR-7853-5p and hsa-miR-200c-3p) and 10 miRNAs in serum (hsa-miR-203a-5p, hsa-miR-495-3p, hsa-miR-4435, hsa-miR-340-5p, hsa-miR-4417, hsa-miR-1266-5p, hsa-miR-4494, hsa-miR-134-3p, hsa-miR-5008-5p, and hsa-miR-6756-5p), that exhibit level changes during pregnancy (p-value adjusted < 0.05). In addition, we observed differences for 36 miRNAs between plasma and serum (p-value adjusted < 0.05), which should be taken into consideration when comparing the results between studies performed using different biosample types. The results were verified by analysis of three miRNAs using qRT-PCR (p < 0.05). The present study confirms that the circulating miRNA profile in blood changes during gestation. Our results set the basis for further investigation of molecular mechanisms, involved in regulation of pregnancy, and the search for biomarkers of gestation abnormalities.
Open AccessHigh-Throughput Sequencing of Circulating MicroRNAs in Plasma and Serum during Pregnancy Progression
Although circulating microRNAs (miRNAs) in maternal blood may play an important role in regulation of pregnancy progression and serve as non-invasive biomarkers for different gestation complications, little is known about their profile in blood during normally developing pregnancy. In this study we evaluated the miRNA profiles in paired plasma and serum samples from pregnant women without health or gestational abnormalities at three time points using high-throughput sequencing technology. Sequencing revealed that the percentage of miRNA reads in plasma and serum decreased by a third compared to first and second trimesters. We found two miRNAs in plasma (hsa-miR-7853-5p and hsa-miR-200c-3p) and 10 miRNAs in serum (hsa-miR-203a-5p, hsa-miR-495-3p, hsa-miR-4435, hsa-miR-340-5p, hsa-miR-4417, hsa-miR-1266-5p, hsa-miR-4494, hsa-miR-134-3p, hsa-miR-5008-5p, and hsa-miR-6756-5p), that exhibit level changes during pregnancy (p-value adjusted < 0.05). In addition, we observed differences for 36 miRNAs between plasma and serum (p-value adjusted < 0.05), which should be taken into consideration when comparing the results between studies performed using different biosample types. The results were verified by analysis of three miRNAs using qRT-PCR (p < 0.05). The present study confirms that the circulating miRNA profile in blood changes during gestation. Our results set the basis for further investigation of molecular mechanisms, involved in regulation of pregnancy, and the search for biomarkers of gestation abnormalities.
- 21 December 2020
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 12_2020
Pathogenesis of COVID-19. Role of heparins in the therapy of severe conditions in patients with COVID-19
- 21 December 2020
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 12_2020
Pathogenesis of COVID-19. Role of heparins in the therapy of severe conditions in patients with COVID-19
- Open Access
- 15 July 2017
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 66 (4) , 79-83
The case of abdominal delivery in acute heteroimmune drug indused thrombocytopenia
The secondary gravida pregnant patient with uterine scar after previous cesarean section was treated with parenteral methamizol sodium due to renal colic and acute thrombocytopenia suddenly occurred. There were supposed that this condition had been drugs induced heteroimmune thrombocytopenia. The indications for planned cesarean section were breech presentation of large fetus in patient with uterine scar. However, uterine contractions appeared in 38/39 weeks and it was decided to deliver the patient urgently after appropriate preparing. The treating of severe thrombocytopenia was substitutive — thromboconcentrate and plasma transfusion and pathogenetic — using of dexamethasone and human immunoglobulin. After transfusion of one dose of thromboconcentrate and two doses of plasma the level of thrombocytes had reached of 21 × 109/л and it was decided to start cesarean section which was performed successfully in conditions of total combined anesthesia with tracheal intubation and pulmonary ventilation. The recovery of thrombocytes quantity occurred in postoperative period with continuing using of steroid therapy.
- 15 July 2017
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 66 (4) , 79-83
Open AccessThe case of abdominal delivery in acute heteroimmune drug indused thrombocytopenia
The secondary gravida pregnant patient with uterine scar after previous cesarean section was treated with parenteral methamizol sodium due to renal colic and acute thrombocytopenia suddenly occurred. There were supposed that this condition had been drugs induced heteroimmune thrombocytopenia. The indications for planned cesarean section were breech presentation of large fetus in patient with uterine scar. However, uterine contractions appeared in 38/39 weeks and it was decided to deliver the patient urgently after appropriate preparing. The treating of severe thrombocytopenia was substitutive — thromboconcentrate and plasma transfusion and pathogenetic — using of dexamethasone and human immunoglobulin. After transfusion of one dose of thromboconcentrate and two doses of plasma the level of thrombocytes had reached of 21 × 109/л and it was decided to start cesarean section which was performed successfully in conditions of total combined anesthesia with tracheal intubation and pulmonary ventilation. The recovery of thrombocytes quantity occurred in postoperative period with continuing using of steroid therapy.